MEDICINE & HEALTH

BioVaxys: Using T-Cell Immune Response for Vaccine Development

BioVaxys: Using T-Cell Immune Response for Vaccine Development

BioVaxys, a biotechnology company and world leader in the development of haptenized protein vaccines, has developed a technology platform implementable against both viruses and cancer cells. With vaccines in development including ones for late-stage ovarian cancer and SARS-CoV-2, their immunotherapeutic approach stimulates a robust response in the production of T-cells, which is a critical breakthrough for fighting viruses and cancer cells, as T-cells directly battle pathogens and tumours by targeting and destroying infected or cancerous cells, and can provide a longer-lasting immune response than by antibodies alone.
BioVaxys - Novel Diagnostic for COVID-19 T-Cell Immunity

BioVaxys - Novel Diagnostic for COVID-19 T-Cell Immunity

With COVID-19 cases rising rapidly across the globe and the little information we know about immunity against it, the global demand for a simple, low-cost, easy-to-administer, and accurate tool to test for the presence of T cells against SARVS-CoV-2 to identify safe and at-risk populations, is increasing.
The Emotional Results of Prolonged Thumb Sucking in Children

The Emotional Results of Prolonged Thumb Sucking in Children

It is a normal coping skill for young children to suck their thumbs, but it can become a problem if the habit remains after the child gets their teeth in. Not only can it cause dental issues requiring care in the future, thumb sucking can cause some serious emotional and psychological development problems.

Recommended Stories